Cover Image
市場調查報告書

美國的HIV/AIDS診斷市場(醫院·血液銀行·公立/民間實驗所·開業醫生):主要的免疫診斷·核酸增幅檢查(NAT)治療相關供應商的市場佔有率·銷售額的預測

2018 U.S. HIV/AIDS Diagnostic Testing Market: HIV 1/2, Combo, Ag, NAT, Western Blot--Supplier Shares and Country Forecasts

出版商 Venture Planning Group 商品編碼 273961
出版日期 內容資訊 英文 250 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
美國的HIV/AIDS診斷市場(醫院·血液銀行·公立/民間實驗所·開業醫生):主要的免疫診斷·核酸增幅檢查(NAT)治療相關供應商的市場佔有率·銷售額的預測 2018 U.S. HIV/AIDS Diagnostic Testing Market: HIV 1/2, Combo, Ag, NAT, Western Blot--Supplier Shares and Country Forecasts
出版日期: 內容資訊: 英文 250 Pages
簡介

本報告提供美國的各種醫療機關(醫院·血液銀行(Blood Banks)·公立/民間實驗所·開業醫生等等)HIV/AIDS診斷上的市場相關分析,提供疾病概要和治療方法,技術開發·活用的最新情形,市場趨勢預測(今後5年份),主要業者的市場佔有率,今後的市場機會與課題,再加上主要企業簡介與市場策略等資訊彙整,為您概述為以下內容。

簡介

全球市場·技術概要

  • 背景
  • 診斷檢驗法:HIV-1/2,HIV Ag,核酸增幅檢查(NAT),西方墨點法
  • 疫苗及藥物
  • 診斷設備的檢討和市場需求
  • 新的診斷技術

美國市場:市場規模·成長率,主要業者的銷售額與市場佔有率

替代性的市場普及策略

  • 內部開發
  • 合資企業協定
  • 與大學的契約
  • 分散式檢查市場流通策略
    • 行銷的方法
    • 產品的複雜性
    • 客戶的偏好
    • 既有廠商
    • 新加入廠商
    • 經銷商的主要類型
    • 市場細分化

加入市場的潛在障礙與風險

  • 市場的成熟度
  • 成本控制
  • 競爭
  • 最尖端科技及其限制
  • 專利保護
  • 法規的限制
  • 分散式檢查市場課題

競爭企業分析

  • Abbott
  • Affymetrix
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • bioMerieux
  • Bio-Rad
  • Cepheid
  • Diamedix
  • DiaSorin
  • 榮研化學
  • Enzo Biochem
  • FUJIREBIO/Innogenetics
  • Hologic/Gen-Probe
  • ID Biomedical/GSK
  • Kreatech
  • Life Technology
  • Lonza
  • Nanogen/Elitech
  • Novartis Diagnostics
  • Ortho-Clinical Diagnostics
  • Qiagen
  • Roche
  • Scienion
  • Sequenom
  • SeraCare
  • Siemens
  • TaKaRa BIO
  • Thermo Fisher
  • Wallac/PE
  • 和光純藥工業

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: VPID29688

Summary

This report presents detailed analyses of the AIDS diagnostics market in the US. The report provides test volume and sales forecasts for HIV/HIV-1/2/Combo, HIVAg/HIV NAT, Western Blot, HTLV-I/II and other confirmatory tests performed in the following market segments:

     - Hospitals
     - Commercial/Private Laboratories
     - Blood Banks
     - Physician Offices
     - Public Health Laboratories

In addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of AIDS tests.

Highlights

  • Provides scientific views on the definition, epidemiology and etiology of AIDS and other retroviruses.
  • Examines market applications of Molecular Diagnostics, Immunodiagnostics, IT and other emerging technologies.
  • Reviews infectious disease testing analyzers marketed by Abbott, Beckman Coulter/Danaher, bioMerieux, Ortho-Clinical Diagnostics/J&J, Roche, Siemens, Tosoh and other suppliers.
  • Profiles leading manufacturers and potential market entrants developing innovative technologies and products.
  • Analyzes alternative market penetration strategies for suppliers.

Methodology

The report is based on a combination of primary and secondary information sources, including VPGMarketResearch’s proprietary database developed during the course of over 100 syndicated studies and numerous proprietary single-client assignments. The database contains information on companies, technologies, products and executives worldwide. Moreover, a comprehensive review of the product and financial literature, business and technical periodicals, and pertinent industry analyst reports was conducted.

Contains 250 pages and 6 tables

Table of Contents

I. Introduction

II. AIDS/HIV Worldwide Market and Technology Overview

  • A. Background
  • B. Diagnostic Tests: HIV-1/2, HIV Ag, NAT, Western Blot
  • C. Vaccines and Drugs
  • D. Instrumentation Review and Market Needs
  • E. Emerging Diagnostic Technologies

III. UK: Market Size, Growth and Major Suppliers' Sales and Market Shares

IV. Alternative Market Penetration Strategies

  • A. Internal Development
  • B. Collaborative Arrangements
  • C. University Contracts
  • D. Distribution Strategies for Decentralized Testing Markets
    • 1. Marketing Approaches
    • 2. Product Complexity
    • 3. Customer Preference
    • 4. Established Suppliers
    • 5. Emerging Suppliers
    • 6. Major Types of Distributors
    • 7. Market Segmentation

V. Potential Market Entry Barriers and Risks

  • A. Market Maturity
  • B. Cost Containment
  • C. Competition
  • D. Technological Edge and Limitations
  • E. Patent Protection
  • F. Regulatory Constraints
  • G. Decentralized Testing Market Challenges

VI. Competitive Assessments

  • Abbott
  • Affymetrix
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • bioMerieux
  • Bio-Rad
  • Cepheid
  • Diamedix
  • DiaSorin
  • Eiken Chemical
  • Enzo Biochem
  • Fujirebio/Innogenetics
  • Hologic/Gen-Probe
  • ID Biomedical/GSK
  • Kreatch
  • Life Technology
  • Lonza
  • Nanogen/Elitech
  • Novartis Diagnostics
  • Ortho-Clinical Diagnostics
  • Qiagen
  • Roche
  • Scienion
  • Sequenom
  • SeraCare
  • Siemens
  • Takara Bio
  • Thermo Fisher
  • Wallac/PE
  • Wako

List of Tables

  • Table1. Major Companies Developing or Marketing AIDS Tests
  • Table 2. UK: HIV or HIV-1/2 Test Volume and Sales Forecast by Market Segment
  • Table 3. UK: HIV Ag Test Volume and Sales Forecast by Market Segment
  • Table 4. UK: Western Blot/Other Confirmatory Tests Volume and Sales Forecast by Market Segment
  • Table 5. UK: HIV NAT Blood Screening Test Volume and Diagnostics Sales
  • Table 6. UK: AIDS Diagnostics Market by Major Supplier
  • Table 7. UK: HIV Blood Screening NAT Sales and Market Shares of Major Suppliers
Back to Top